https://www.selleckchem.com/pr....oducts/gsk2578215a.h
The aim of this study was to compare the efficacy, safety, and duration of Remebot robot-assisted frameless brain biopsy with those of standard frame-based stereotactic biopsy. A retrospective analysis of 66 patients undergoing stereotactic brain biopsy in our department from January 2015 to January 2019 was performed. We divided the patients into two groups the frame-based group ( = 35) and the Remebot robot group ( = 31). Data on clinical characteristics, total procedure length, overall discomfort, diagnostic yield, complication
Like
Comment
Share
